Hitachi Aloka Medical America Inc. announced the creation of a new dedicated sales force targeting cardiovascular ultrasound opportunities in physician’s offices and hospitals.

AirStrip and Life Monitor Pty Ltd. announced the formation of a strategic partnership to sell AirStrip solutions in Australia and New Zealand. Both the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system will be available as part of the agreement.

Merge Healthcare announced it recently acquired DR Systems Inc. for about $70 million. DR Systems is a privately held San Diego-based company in medical imaging information systems.

MarketReportsOnline.com adds "Global Radiation Therapy Market Report: 2015 Edition" report that says worldwide radiation therapy market has shown significant growth over the past few years, with North America as the highly competitive and largest market for radiotherapy devices.

A Noble Hospital breast surgeon's work with a new device that improves treatment of breast cancers will be featured later this month at a prestigious international medical conference.

By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly used clot-busting technique. The finding, reported in Advanced Functional Materials, is based on experiments in human blood and mouse clotting models.

Hielscher, Columbia, PAD, OCT, diabetes, optical tomographic imaging, peripheral

Approximately 8 to 12 million people in the United States alone are suffering from peripheral arterial disease (PAD), a common vascular problem that is also one of the most serious complications of diabetes. Andreas Hielscher, professor of biomedical engineering, electrical engineering and radiology (physics) at Columbia Engineering, is developing a novel technology that could improve diagnosis of this crippling disease and make it easier to monitor patients.

Investigators from Dartmouth College’s Norris Cotton Cancer Center have discovered how the complex parts of the blue light known as the Cherenkov effect can be measured and used in dosimetry to make radiation therapies safer and more effective. Findings of the study, led by Brian W. Pogue, Ph.D., and Ph.D. candidates Adam K. Glaser and Rongxiao Zhang, were published in the journal Physics in Medicine and Biology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now